Naturally occurring phenylethanoids and phenylpropanoids: antimalarial potential.

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Malaria remains a significant global health threat caused by the Plasmodium parasite.
• There is a critical need for novel antimalarial drugs due to emerging resistance.
• Natural products represent a valuable resource for identifying new bioactive compounds.

Purpose of the Study:

• To investigate the antimalarial potential of naturally occurring phenylpropanoids and phenylethanoids.
• To identify promising chemical leads for the development of new antimalarial therapies.
• To evaluate the antiplasmodial activity of glandularin against Plasmodium falciparum.

Main Methods:

• In silico analysis of naturally-occurring phenylpropanoids and phenylethanoids for binding affinity.
• Computational docking against key Plasmodium falciparum targets: PfPK5, cyt bc1, and PfKRS1.
• In vitro assessment of glandularin's antiplasmodial activity using a SYBR green I-based fluorescence assay.

Main Results:

• Twenty-five phenylpropanoid and phenylethanoid compounds exhibited moderate to strong binding affinity to Plasmodium falciparum targets.
• Glandularin demonstrated high antimalarial activity against the chloroquine-sensitive 3D7 strain of P. falciparum.
• An IC50 value of 11.2 μM was recorded for glandularin after 24 hours of incubation.

Conclusions:

• Phenylpropanoids and glandularin are identified as promising chemical leads for antimalarial drug development.
• The study supports the exploration of natural products for novel anti-infective agents.
• Further research into glandularin and related compounds could lead to effective malaria treatments.